[1] 刘成海, 刘平, 胡义扬, 朱大元.丹酚酸B盐对转化生长因子-β1刺激肝星状细胞活化与胞内信号转导的作用[J].中华医学杂志, 2002, 82(18):1267-1272. [2] Trim N, Morgan S, Evans M, et al. Hepatic stellate cells express the low affinity nerve growth factor receptor P75 and undergo apoptosis in response to nerve growth factor stimulation [J]. The American Journal Pathology, 2005, 156(4):1235-1243. [3] 程明亮.细胞信号转导与功能蛋自质组学在肝纤维化发生机制研究中的新动向[J].中西医结合肝病杂志, 2005, 15:193-194. [4] 赖允丽, 张学荣, 张钦乐, 等.眼镜蛇毒神经生长因子抑制肝星状细胞增殖并诱导其凋亡[J].现代生物医学进展, 2012, 12(6):1034-1039. [5] Mama F. Chemokines in liver inflammation and fibrosis [J]. Front Biosci, 2002, 7:1899-1914. [6] Elsharkawy A, Oakley F, Mann D. The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis [J]. Apoptosis, 2005, 10:927-939. [7] Prieto J, Qian C, Hernandez R, et al. Gene therapy of liver diseases [J]. Expert Opinion Biological Therapy, 2004, 4(7):1073-1091. [8] Lutz M, Knaus P. Integration of the TGF-β pathway into the cellular signaling network [J]. Cell Signal, 2002, 14(12):977-988. [9] Massagué J. How cell read TGF-β signals [J]. Nat Rev Mol Cell Biol, 2000, 1:169-178. [10] Aloe L, Bracci-Laudiero L, Bonini S, et al. The expanding role of nerve growth factor:from neurotrophic activity to immunologic diseases [J]. Allergy, 1997, 52(9):883-894. [11] McAllister AK. Neurotrophins and neuronal differentiation in the central nervous system [J]. Cellular and Molecular Life Sciences, 2001, 58(8):1054-1060. [12] Massague J, Chen YG. Controlling TGF-beta signaling [J]. Genes Dev, 2000, 14(6):627-644. [13] Padua D, Massague J. Roles of TGF-β in metastasis [J]. Cell Res, 2009, 19:89-102. [14] Yongchaitrakul T, Pavasant P. Transforming growth factor-beta1 up-regulates the expression of nerve growth factor through mitogen-activated protein kinase signaling pathways in dental pulp cells [J]. European Journal of Oral Sciences, 2007, 115(1):57-63. [15] De Simone R, Ambrosini E, Carnevale D, et al. NGF promotes microglial migration through the activation of its high affinity receptor:modulation by TGF-β [J]. Journal of Neuroimmunology, 2007, 190(1-2):53-60. [16] Brand?o DF, Ramalho LN, Ramalho FS, et al. Liver cirrhosis and hepatic stellate cells [J]. Acta Cir Bras, 2006, 21(1):54-57. [17] Liu C, Gaca MD, Swenson ES, et al. Smads 2 and 3 are differentially activated by transforming growth factor-β (TGF-β) in quiescent and activated hepatic stellate cells [J]. The Journal of Biological Chemistry, 2003, 278(13):11721-11728. [18] Schnabl B, Kweon YO, Frederick JP, et al. The role of Smad3 in mediating mouse hepatic stellate cell activation [J]. Hepatology, 2001, 34(1):89-100. [19] Subeq YM, Ke CY, Lin NT, et al. Valsartan decreases TGF-β1 production and protects against chlorhexidine digluconate induced liver peritoneal fibrosis in rats [J]. Cytokine, 2011, 53(2):223-230. [20] Cheng K, Yang N, Mahato RI. TGF-beta1 gene silencing for treating liver fibrosis [J]. Molecular Pharmaceutics, 2009, 6(3):772-779. [21] Bissell DM, Roulot D, George J. Transforming growth factor beta and the liver[J]. Hepatology, 2001, 34(5):859-867. |